We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Investing.com -- Inari Medical Inc (NASDAQ ... a condition where blood clots form in veins, as well as other vascular diseases. Stryker will pay $80 per share for Inari, as initially reported ...

Stryker is now opening its pocketbook a bit wider to acquire Inari Medical with its portfolio of blood-clot-busting devices and 1,400 employees. Stryker will put down $80 per share in cash for ...

As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical ... where a blood clot forms in a vein, and other vascular diseases.

New York: Medical-device maker Stryker on Monday agreed to acquire Inari Medical ... where a blood clot forms in a vein, and other vascular diseases. Under the terms of the deal, which was ...

Inari’s portfolio of medical devices and accessories to treat venous thromboembolism (VTE), or blood clots in the veins, was highly attractive to Stryker, according to Inari Chief Executive Drew Hykes ...

Stryker acquires Inari Medical for $80/share ... VTE is a term for blood clots in the veins, which can lead to serious illness, disability, or death. Inari’s product portfolio complements ...

After the MedTech giant Stryker (NYSE:SYK) agreed to offer $4.9B in cash to acquire Inari Medical (NASDAQ:NARI), a maker of clot removal systems, shares of its rival Penumbra (NYSE:PEN ...

1 Inari provides solutions for VTE clot removal without the use of thrombolytic ... About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven ...